Day: March 8, 2022

Ayala Pharmaceuticals, MD Anderson Cancer Center and the Adenoid Cystic Carcinoma Research Foundation Announce Initiation of Enrollment in Window of Opportunity Study of AL101 in Adenoid Cystic Carcinoma

Window of Opportunity Study is Evaluating AL101 Administered Prior to Surgery in Patients with Advanced, Notch-activated ACCREHOVOT, Israel and WILMINGTON,...

error: Content is protected !!